Use for PCOS is considered off-label, though doctors may prescribe it to help manage insulin resistance, support weight loss, or address other PCOS-related symptoms
If you're experiencing minimal hunger suppression, plateau weight loss, or excellent tolerance without side effects, dose escalation becomes clinically appropriate
Further additional studies should be conducted with higher statistical power to confirm the observed associations
Research Applications Renew Spray is formulated for researchers investigating growth-related processes, exploring potential synergies between CJC-1295 No DAC and Ipamorelin, and studying therapeutic applications related to growth hormone regulation
New research from Simple Online Healthcare suggests oral treatments will significantly expand access to obesity care: 61% of people not currently using GLP-1 medications say they would prefer a daily pill Nearly half of existing GLP-1 users prefer a pill format However, existing patients remain focused on effectiveness 88% saying they would only switch if tablets deliver equal or higher results
It may also be used to maintain weight loss